Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics
High cancer death rates indicate the need for new anticancer therapeutic agents. Approaches to discovering new cancer drugs include target-based drug discovery and phenotypic screening. Here, we identified phosphodiesterase 3A modulators as cell-selective cancer cytotoxic compounds through phenotypi...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2017
|
Online Access: | http://hdl.handle.net/1721.1/106947 |